Status not kept up to date
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
NCT02760667 · George Washington University · Updated 27 June 2023
- What is being tested
- Cisplatinum; Docetaxel; Carboplatin; Transoral Robotic Assisted Surgery
- For
- Head and Neck Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 20 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started June 2015, ends 30 Dec 2023. Registered 4 May 2016.
- Results
- None posted yet.
In the researchers' words
The objective of this study is to assess the efficacy of induction chemotherapy followed by transoral surgical treatment and neck dissection, in definitive management of moderately advanced oropharyngeal squamous cell carcinoma. The surgical treatment will carry out Transoral Robotic Surgery (TORS) or Transoral Laser Microsurgery (TLM) for the primary tumor, and neck dissection for the management of cervical lymph nodes. The primary outcome measure will be disease specific survival (DSS). The secondary oncologic outcome measures will be locoregional control, relapse free survival, overall survival, and Quality of Life (QOL).
Sites
- George Washington University-Medical Faculty AssociatesWashington D.C., District of Columbia, United States